Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_assertion type Assertion NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_head.
- NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_assertion description "[The results also demonstrate that cells modified to contain the herpes simplex virus-thymidine kinase (HSV-tk) gene under control of the EGR-1 promoter become sensitive to treatment with the antiviral agent ganciclovir (GCV), whereas nonirradiated cells and nontransfected cells were unaffected by this agent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_provenance.
- NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_assertion evidence source_evidence_literature NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_provenance.
- NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_assertion SIO_000772 8664375 NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_provenance.
- NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_assertion wasDerivedFrom befree-20140225 NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_provenance.
- NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_assertion wasGeneratedBy ECO_0000203 NP615827.RAr6r47H2Z2fjqtQM8BC9G1VoaIZH6uaPFN2Rw-tAdmkc130_provenance.